Habib Dable
Chairman chez AEROVATE THERAPEUTICS, INC.
Fortune : 616 590 $ au 31/03/2024
Profil
Habib J. Dable est actuellement président, chef de la direction et directeur d'Acceleron Pharma, Inc. Il a précédemment occupé le poste de président des produits pharmaceutiques américains chez Bayer AG et EVP & Global Head- Specialty Medicine chez Bayer HealthCare Pharmaceuticals, Inc. (une filiale de Bayer AG). Il est titulaire d'un MBA et d'un diplôme de premier cycle de l'Université du Nouveau-Brunswick.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/06/2023 | 6 500 ( 0,01% ) | 616 590 $ | 31/03/2024 | |
| 17/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 | |
| 04/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 | |
PEPGEN INC.
-.--% | 15/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Habib Dable
| Sociétés | Poste | Début |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director/Board Member | 23/06/2022 |
| PEPGEN INC. | Director/Board Member | 22/09/2022 |
| AEROVATE THERAPEUTICS, INC. | Chairman | 06/03/2024 |
| DAY ONE BIOPHARMACEUTICALS, INC. | Director/Board Member | 17/01/2024 |
Anciens postes connus de Habib Dable
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 02/03/2023 |
| ACCELERON PHARMA INC. | Chief Executive Officer | 19/11/2021 |
| MILLENDO THERAPEUTICS | Director/Board Member | 31/01/2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01/01/2017 |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Corporate Officer/Principal | 01/12/2016 |
Formation de Habib Dable
| University of New Brunswick | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BAYER AG | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| AEROVATE THERAPEUTICS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
| PepGen Inc. |
